Been digging through some older investment opportunities and found something worth revisiting. Back in 2023, there were some solid penny stocks to buy in 2023 that caught traders' attention for different reasons. Let me break down three that had real catalysts worth understanding.

First up was Savara, a biotech company working on rare respiratory diseases. They were running a Phase 3 trial called IMPALA-2 for a treatment targeting a rare lung condition. What made this interesting was they actually exceeded their enrollment target of 160 patients, hitting 164 instead. They had solid cash position too, around $105 million at mid-2023, plus they raised another $80 million through a stock offering. The real catalyst was waiting for trial results they expected by end of Q2 2024. For anyone looking at penny stocks to buy in 2023, this was one where you could see the value drivers clearly.

Then there was Canaan, the Bitcoin mining hardware company. These guys were selling serious computing power in Q2 2023, hitting 6.1 million Thash/s which was up 44% from the previous quarter. Revenue came in at $73.9 million, up from $55.2 million the quarter before. Mining revenue alone was $15.9 million. But they hit some speed bumps when Kazakhstan introduced new licensing requirements for crypto mining, forcing them to pause about half their computing power in Central Asia. Still, they landed a partnership with a major mining operation that ordered 11,000 new machines. Classic penny stocks to buy in 2023 story - growth with some regulatory headwinds.

Ardelyx was the pharma play. Their main product IBSRELA was generating real revenue, $18.3 million in Q2 alone with expectations to hit $72-77 million for the full year. They had $127.6 million in cash, which gave them runway. They also got their new drug application accepted for a chronic kidney disease treatment in China, with $2 million upfront payment and approval expected by end of 2024. In the US, they were waiting on FDA review for another drug, targeting October 2023 for decision. These were the kinds of penny stocks to buy in 2023 because the catalysts were concrete - regulatory approvals and revenue ramp.

Looking back now, this was a snapshot of what made penny stocks interesting that year. Each had different value drivers, whether clinical trials, hardware sales, or pharma approvals. The broader lesson was always the same - find the catalysts and follow them.